NAVENIBART
UNII 975UQE9GY6

Substance Identification & Data

This profile provides standardized clinical and technical data for Navenibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 975UQE9GY6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2803430-16-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

975UQE9GY6

CAS Registry Number

2803430-16-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NAVENIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C203148

National Cancer Institute reference terminology for clinical and research data.

INN ID

12991

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-72

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Navenibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NAVENIBART

Common Names & Synonyms

IMMUNOGLOBULIN G1 (256-TYROSINE,258-THREONINE,260-GLUTAMIC ACID,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN PLASMA KALLIKREIN) (HUMAN-MUS MUSCULUS MONOCLONAL STAR-0215 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL STAR-0215 .KAPPA.-CHAIN, DIMER

NAVENIBART [INN]

NAVENIBART [USAN]